Komori

Articles of Incorporation 2022/08/25

2022年8月25日付で定款を改訂した。ただし、本文には改訂前からの具体的な変更内容は示されていない。

Worth reading
52Recurring
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit & Supervisory Board
Number of directorsNo more than 12 (number of outside directors: Not disclosed)
Changes this time

2022年8月25日に改訂されたこと、および附則が自動抹消されたこと以外の変更点はNot disclosed

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit & Supervisory Board
Number of directorsNo more than 12 (number of outside directors: Not disclosed)
Changes this time2022年8月25日に改訂されたこと、および附則が自動抹消されたこと以外の変更点はNot disclosed
Items this document does not state (5)
Number of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

改訂の理由は本文に記載されていない。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2022/08/25 | Pharmarise Holdings Corporation (2796) timely disclosure | Komori